The federal government provides the Swedish Medicines Company the duty of, in collaboration with a number of different authorities, rising the data of the related actors about ADHD and the usage of ADHD medicines in Sweden. The objective is to advertise equal, protected and efficient care.
ADHD is among the commonest psychiatric situations amongst youngsters and younger individuals in Sweden. The Nationwide Board of Well being and Welfare estimates that 10.5 p.c of boys and 6 p.c of women had an ADHD analysis in 2022. In line with the company’s forecast, the share with a analysis is predicted to extend to fifteen p.c for boys and 11 p.c for ladies earlier than the pattern ranges off.
– The rise in analysis and withdrawal of adhd medication that has occurred and appears set to proceed exhibits the necessity for elevated data within the adhd space. Because the earlier remedy advice got here in 2016, there have been new medication, new analysis and expanded indicators. It’s time to do a brand new evaluation, in order that extra individuals get the suitable assist on the proper time, says Minister of Social Affairs Jakob Forssmed.
The task to the Medical Merchandise Company contains reviewing whether or not extra medical doctors ought to have the ability to prescribe ADHD treatment. As we speak, all prescribing, together with renewal of prescriptions, should happen inside specialist care.
– The rise in ADHD treatment has clearly contributed to the truth that little one and youth psychiatry has issue fulfilling its mission. We’re subsequently giving the authority the duty of analyzing the implications of prolonged prescribing rights for ADHD treatment, says Minister of Social Affairs Jakob Forssmed.
Extra concerning the task to the Medical Merchandise Company
The task contains a number of measures:
- Surveys: The Swedish Medicines Company will perform surveys to extend data about ADHD, together with prevalence, prescription and drug use.
- Validation of analysis: By way of document evaluation, the Medical Merchandise Company should create situations for validating the ADHD analysis in response to knowledge-based standards.
- Analyzes and forecasts: The Swedish Medicines Company will develop analyzes and forecasts to raised perceive developments and wishes within the ADHD space.
- Replace of remedy suggestions: Present remedy advice for ADHD medication for kids, adolescents and adults might be reviewed and up to date.
- Investigation of prolonged prescription rights: The results of an prolonged prescription proper for adhd medication might be investigated.
The Swedish Medicines Company should work in shut collaboration with related authorities and different actors.
The Swedish Medicines Company receives this task inside the framework of the federal government’s work with psychological well being and suicide prevention and to create situations for attaining the aims within the nationwide technique for work within the pharmaceutical space 2024–2026 (S2024/00190).
